Literature DB >> 9286281

Endothelial metaplasia in the iridocorneal endothelial syndrome.

D N Howell1, T Damms, J L Burchette, W R Green.   

Abstract

PURPOSE: To test the hypothesis that the aberrant, cytokeratin-expressing cells that replace endothelium in the iridocorneal endothelial (ICE) syndrome are of endothelial origin.
METHODS: Corneas from four patients with Chandler's syndrome and three with essential iris atrophy were examined by two-color immunofluorescence for simultaneous expression of cytokeratins and two markers of endothelial lineage: vimentin and the antigen recognized by the antiendothelial monoclonal antibody 2B4.14.1.
RESULTS: In six corneas, unequivocal endothelial staining for cytokeratins was present; in each of these, cells coexpressing cytokeratins and the two endothelial markers were clearly identifiable. In the remaining cornea, weak cytokeratin staining that colocalized with vimentin was present.
CONCLUSIONS: These results lend strong support to the hypothesis that the "epithelial-like" endothelial cells in ICE syndrome are cells of endothelial lineage rather than heterotopia of epithelial cells; these cells probably arise via a metaplastic transformation of preexisting endothelium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286281

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Confocal microscopy in the iridocorneal endothelial syndrome.

Authors:  A G Chiou; S C Kaufman; R W Beuerman; T Ohta; V Yaylali; H E Kaufman
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

2.  The PPCD1 mouse: characterization of a mouse model for posterior polymorphous corneal dystrophy and identification of a candidate gene.

Authors:  Anna L Shen; Kathleen A O'Leary; Richard R Dubielzig; Norman Drinkwater; Christopher J Murphy; Charles B Kasper; Christopher A Bradfield
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

3.  In-vivo confocal microscopy of iridocorneal endothelial syndrome.

Authors:  Qi-Hua Le; Xing-Huai Sun; Jian-Jiang Xu
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

4.  Unique variations and characteristics of iridocorneal endothelial syndrome in China: a case series of 58 patients.

Authors:  Bo Feng; Xin Tang; Hong Chen; Xia Sun; Ningli Wang
Journal:  Int Ophthalmol       Date:  2017-10-10       Impact factor: 2.031

Review 5.  Diseases of the corneal endothelium.

Authors:  Lauren J Jeang; Curtis E Margo; Edgar M Espana
Journal:  Exp Eye Res       Date:  2021-02-14       Impact factor: 3.467

Review 6.  Progenitors for the corneal endothelium and trabecular meshwork: a potential source for personalized stem cell therapy in corneal endothelial diseases and glaucoma.

Authors:  Wing Yan Yu; Carl Sheridan; Ian Grierson; Sharon Mason; Victoria Kearns; Amy Cheuk Yin Lo; David Wong
Journal:  J Biomed Biotechnol       Date:  2011-12-06

Review 7.  Iridocorneal endothelial syndrome: clinical perspectives.

Authors:  Andrew Walkden; Leon Au
Journal:  Clin Ophthalmol       Date:  2018-04-09

Review 8.  Diagnosis and Management of Iridocorneal Endothelial Syndrome.

Authors:  Marta Sacchetti; Flavio Mantelli; Marco Marenco; Ilaria Macchi; Oriella Ambrosio; Paolo Rama
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

9.  Association of a Chromosomal Rearrangement Event with Mouse Posterior Polymorphous Corneal Dystrophy and Alterations in Csrp2bp, Dzank1, and Ovol2 Gene Expression.

Authors:  Anna L Shen; Susan A Moran; Edward A Glover; Norman R Drinkwater; Rebecca E Swearingen; Leandro B Teixeira; Christopher A Bradfield
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

10.  Retinal pathology in the PPCD1 mouse.

Authors:  Anna L Shen; Susan M Moran; Edward A Glover; Leandro B Teixeira; Christopher A Bradfield
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.